SINGAPORE, 11 May 2017 – Raman Singh, Mundipharma’s CEO has been ranked seventh most prominent Business Captain among a list of the top 100 pharmaceutical sector leaders by UK-based industry publication, The Medicine Maker.
The Medicine Maker’s Power List ranks the top 100 individuals with the most significant impact on the world of medicine. This year, the publication evolved its rankings into four categories each featuring 25 business leaders under ‘Masters of the Bench’, ‘Industry Influencers’, ‘Business Captains’ and ‘Champions of Change’.
Mr Singh’s high ranking in the ‘Business Captains’ category puts him among leaders and entrepreneurs ‘who turn scientific ideas into marketable medicines’. The Power List features top executives, scientists and other professionals from leading companies and prestigious institutions.
This is the third year running that Mr Singh is in the top 10 of the Medicine Maker’s list, ranking fourth last year in an overall top 100 Power List, and sixth in the same list in 2015.
Acknowledging his ranking, Mr Singh commented: “I am again honoured and humbled to be named among the leading captains of business at a time when there is a clear call for strong industry leadership to close the gap between mature and emerging worlds.”
“Business leadership empowered by technology innovation and business agility can improve access and reach of healthcare services while giving patients greater control over their treatment,” he added.
Nominees of the Medicine Maker Power List were evaluated and ranked by each individual judge on the judging panel. The rankings were then averaged to obtain the final Power List.
The Medicine Maker Power List 2017 and its four sub-categories were published in the magazine’s most recent April 2017 edition. An online version is available on the magazine’s website here.
For further information please contact:
Chief Communications Officer & Head, Digital Strategy
Asia Pacific, Middle East, Africa & Latin America
+65-6303-9732 | firstname.lastname@example.org
Mundipharma’s independent associated companies are privately owned entities covering pharmaceutical markets in Asia-Pacific, Latin America, Middle East and Africa. The headquarters for these territories is in Singapore. Mundipharma is a prime example of a company that consistently delivers high quality products while standing by the values that represent the company. Our mission is to alleviate the suffering of patients and to substantially improve their quality of life. Mundipharma is dedicated to bringing to patients with severe and debilitating diseases the benefit of novel treatment options in fields such as pain, oncology, oncology supportive care, ophthalmology, respiratory disease and consumer healthcare.
For more information please visit: www.mundipharma.com.sg